Top-News

IMMUNOVACCINE INC News

Aktie
WKN:  A1J45A ISIN:  CA45254B1031
Keine aktuellen Kursdaten verfügbar
Handeln Depot/Watchlist
Dieses Wertpapier ist nicht mehr handelbar.
Aktienanzahl *
-
Marktkapitalisierung *
-
Streubesitz
-
Index-Zugehörigkeit
-

IMMUNOVACCINE INC News

22.04.21 - PR Newswire
Immunovia reiterates its road to reimbursement for the IMMray™ PanCan-d test
Immunovia reiterates its road to reimbursement for the IMMray™ PanCan-d test PR Newswire
22.04.21 - PR Newswire
Immunovia reiterates its road to reimbursement for the IMMray™ PanCan-d test
Immunovia reiterates its road to reimbursement for the IMMray™ PanCan-d test PR Newswire
29.03.21 - PR Newswire
Immunovia reports improved test performance of IMMrayTM PanCan-d in detecting early stage pancreatic cancer in high risk symptomatic patients
Immunovia reports improved test performance of IMMrayTM PanCan-d in detecting early stage pancreatic cancer in high risk symptomatic patients Stage I/II pancreatic cancer was ...
15.02.21 - PR Newswire
Immunovia's PanFAM-1 Prospective Study Gathers Over 3000 Familial Hereditary Pancreatic Cancer Risk Samples And Will Be Analysed In The Second Half Of 2021
Immunovia's PanFAM-1 Prospective Study Gathers Over 3000 Familial Hereditary Pancreatic Cancer Risk Samples And Will Be Analysed In The Second Half Of 2021 PR Newswire
15.02.21 - PR Newswire
Immunovia's PanFAM-1 Prospective Study Gathers Over 3000 Familial Hereditary Pancreatic Cancer Risk Samples And Will Be Analysed In The Second Half Of 2021
Immunovia's PanFAM-1 Prospective Study Gathers Over 3000 Familial Hereditary Pancreatic Cancer Risk Samples And Will Be Analysed In The Second Half Of 2021 PR Newswire
19.01.21 - PR Newswire
Chief Executive Officer, Patrik Dahlen Buys Immunovia Warrants
Chief Executive Officer, Patrik Dahlen Buys Immunovia Warrants PR Newswire
19.01.21 - PR Newswire
Chief Executive Officer, Patrik Dahlen Buys Immunovia Warrants
Chief Executive Officer, Patrik Dahlen Buys Immunovia Warrants PR Newswire
07.01.21 - PR Newswire
Proteomic data derived from Immunovia's IMMray™-platform allows differential diagnosis of difficult to distinguish autoimmune diseases
Proteomic data derived from Immunovia's IMMray™-platform allows differential diagnosis of difficult to distinguish autoimmune diseases PR Newswire
07.01.21 - PR Newswire
Proteomic data derived from Immunovia's IMMray™-platform allows differential diagnosis of difficult to distinguish autoimmune diseases
Proteomic data derived from Immunovia's IMMray™-platform allows differential diagnosis of difficult to distinguish autoimmune diseases PR Newswire
09.12.20 - PR Newswire
TMX Group, IMV, C-Suite at The Open
TMX Group, IMV, C-Suite at The Open Canada NewsWire
10.11.20 - PR Newswire
Nomination Committee appointed for the 2021 Annual General Meeting of Immunovia AB (Publ)
Nomination Committee appointed for the 2021 Annual General Meeting of Immunovia AB (Publ) PR Newswire
10.11.20 - PR Newswire
Nomination Committee appointed for the 2021 Annual General Meeting of Immunovia AB (Publ)
Nomination Committee appointed for the 2021 Annual General Meeting of Immunovia AB (Publ) According to the instructions for the Nomination Committee of Immunovia AB (Publ) ...
02.11.20 - PR Newswire
Immunovia Provides Complementary Details on the IMMray™ PanCan-d Verification Study
Immunovia Provides Complementary Details on the IMMray™ PanCan-d Verification Study PR Newswire
02.11.20 - PR Newswire
Immunovia Provides Complementary Details on the IMMray™ PanCan-d Verification Study
Immunovia Provides Complementary Details on the IMMray™ PanCan-d Verification Study PR Newswire
28.10.20 - PR Newswire
Immunovia to Host Webinar Introducing New CEO, Patrik Dahlen
Immunovia to Host Webinar Introducing New CEO, Patrik Dahlen PR Newswire
28.10.20 - PR Newswire
Immunovia to Host Webinar Introducing New CEO, Patrik Dahlen
Immunovia to Host Webinar Introducing New CEO, Patrik Dahlen PR Newswire
02.09.20 - PR Newswire
Immunovia Announces Management Team Changes
Immunovia Announces Management Team Changes PR Newswire
02.09.20 - PR Newswire
Immunovia Announces Management Team Changes
Immunovia Announces Management Team Changes PR Newswire
28.08.20 - PR Newswire
Registration Details for Immunovia's Second Webinar in the Series on IMMray™ PanCan-d: Commercial Test Model Study & Update on Launch Activities
Registration Details for Immunovia's Second Webinar in the Series on IMMray™ PanCan-d: Commercial Test Model Study & Update on Launch Activities PR Newswire
20.08.20 - PR Newswire
Immunovia Reports Second Quarter Interim Report January - June 2020
Immunovia Reports Second Quarter Interim Report January - June 2020 PR Newswire

Newssuche

Videos

newspaper
17.05.24 -4,89%
Technical Trading: Gold Long-​Chance
Gold Long Typ: Turbo Open End WKN: VD1G7Y Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »